Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Health Canada expands approved uses of Rebetron

May 3, 1999

Pivotal results demonstrate equal efficacy and better tolerability of Diacol versus NuLYTELY

May 3, 1999

Anti-HBV agents in development at Australian research center

May 3, 1999

SK-951 identified as a potent 5-HT4 agonist/5-HT3 antagonist

April 30, 1999

European CPMP emits positive opinion on Zeffix for chronic HBV

April 27, 1999

U.S. study now under way using artificial liver device incorporating human cells

April 27, 1999

Thalidomide receives orphan drug status for Crohn's disease

April 21, 1999

SciClone and Sigma-Tau sign Zadaxin partnership

April 19, 1999

COX-2 inhibitors can potentially be used safely in patients with decompensated cirrhosis

April 19, 1999

Low-dose IL-2 provides benefits in treatment-refractory HCV patients

April 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...